Cargando…

Clinical and Economic Burden of Commercially Insured Patients with Acromegaly in the United States: A Retrospective Analysis

BACKGROUND: Acromegaly is a chronic disorder characterized by excess growth hormone secretion and elevated insulin-like growth factor-1 levels most often caused by a pituitary adenoma. Clinical presentation of the disease includes coarsening of the facial features, soft-tissue swelling of the hands...

Descripción completa

Detalles Bibliográficos
Autores principales:	Placzek, Hilary, Xu, Yaping, Mu, Yunming, Begelman, Susan M., Fisher, Maxine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397952/ https://www.ncbi.nlm.nih.gov/pubmed/26679960 http://dx.doi.org/10.18553/jmcp.2015.21.12.1106

Ejemplares similares

Economic Burden of HIV in a Commercially Insured Population in the United States
por: Chen, Cindy Y., et al.
Publicado: (2023)

The economic burden of NIPC and BOS following allogeneic HSCT in patients with commercial insurance in the United States
por: Sacks, Naomi C., et al.
Publicado: (2022)

2145. Economic Burden of Congenital Cytomegalovirus Infection in Commercially- and Medicaid-insured Patients in the United States
por: Diaz-Decaro, John D, et al.
Publicado: (2022)

Economic burden related to fistulas or strictures among commercially insured patients with Crohn’s disease in the United States
por: Fan, Yanni, et al.
Publicado: (2023)

Economic burden of interstitial lung disease in a commercially insured population with Sjögren syndrome in the United States
por: Lee, Tsung-Ying, et al.
Publicado: (2022)

Clinical and economic burden of prescribing tramadol and other opioids for patients with osteoarthritis in a commercially insured population in the United States
por: Silverman, Stuart, et al.
Publicado: (2022)

Healthcare Utilization and Cost Burden of Porphyria in Commercially Insured Adults in the United States
por: Elsaid, Mohamed I., et al.
Publicado: (2020)

Economic Burden of Metastatic Ovarian Cancer in a Commercially Insured Population: A Retrospective Cohort Analysis
por: Chin, Lauren, et al.
Publicado: (2020)

Economic burden of major bleeding events in commercially insured patients with von Willebrand disease based on claims data from the United States
por: Lu, Mei, et al.
Publicado: (2021)

Wilson’s Disease: An Analysis of Health Care Use and Cost Burden of Commercially Insured Adults in the United States
por: Rustgi, Vinod K., et al.
Publicado: (2021)

Treatment Patterns and Economic Burden in Patients Treated for Acromegaly in the USA
por: Chuang, Chien-Chia, et al.
Publicado: (2015)

Disease and Economic Burden Associated with Recurrent Pericarditis in a Privately Insured United States Population
por: Lin, David, et al.
Publicado: (2021)

Economic Burden of Irritable Bowel Syndrome with Constipation: A Retrospective Analysis of Health Care Costs in a Commercially Insured Population
por: Doshi, Jalpa A., et al.
Publicado: (2014)

Economic and Clinical Burden of Acute Myeloid Leukemia Episodes of Care in the United States: A Retrospective Analysis of a Commercial Payer Database
por: Pandya, Bhavik J., et al.
Publicado: (2020)

A retrospective study of HIV antiretroviral treatment persistence in a commercially insured population in the United States
por: Juday, Timothy, et al.
Publicado: (2011)

Economic Burden of Anemia in an Insured Population
por: Nissenson, Allen R., et al.
Publicado: (2005)

Economic burden of acute steroid-refractory graft-versus-host disease in commercially insured pediatric patients
por: Grabner, Michael, et al.
Publicado: (2021)

Sporotrichosis Cases in Commercial Insurance Data, United States, 2012–2018
por: Benedict, Kaitlin, et al.
Publicado: (2020)

Postpartum care visits among commercially insured women in the United States
por: Butwick, Alexander J., et al.
Publicado: (2022)

Epidemiology of rhegmatogenous retinal detachment in commercially insured myopes in the United States
por: Ludwig, Cassie A., et al.
Publicado: (2023)

A systematic literature review of the clinical and health economic burden of schizophrenia in privately insured patients in the United States
por: Zhang, Wenjie, et al.
Publicado: (2018)

The Economic Burden of Eosinophilic Gastritis and Eosinophilic Enteritis in the United States
por: Woolley, Michael, et al.
Publicado: (2022)

The Pharmacological Burden of Comorbidities in Acromegaly
por: Fleseriu, Maria, et al.
Publicado: (2021)

Causes of Death among Commercially Insured Multiple Sclerosis Patients in the United States
por: Goodin, Douglas S., et al.
Publicado: (2014)

Presumed ocular histoplasmosis syndrome in a commercially insured population, United States
por: Benedict, Kaitlin, et al.
Publicado: (2020)

Economic Burden of Sanfilippo Syndrome in the United States
por: Ashby, Frederick, et al.
Publicado: (2023)

Clinical and cost burden of rotavirus infection before and after introduction of rotavirus vaccines among commercially and Medicaid insured children in the United States
por: Krishnarajah, Girishanthy, et al.
Publicado: (2014)

Cardiovascular Risk of Concomitant Use of Atypical Antipsychotics and Stimulants Among Commercially Insured Youth in the United States
por: Zhang, Chengchen, et al.
Publicado: (2021)

Research on the Effect of Commercial Health Insurance Development on Economic Efficiency
por: Zhao, Tongpu, et al.
Publicado: (2023)

Economic burden of chronic bronchitis in the United States: a retrospective case-control study
por: Blanchette, Christopher M, et al.
Publicado: (2011)

Treatment patterns, adverse events, and economic burden in a privately insured population of patients with chronic lymphocytic leukemia in the United States
por: Kabadi, Shaum M., et al.
Publicado: (2019)

Coccidioidomycosis Skin Testing in a Commercially Insured Population, United States, 2014–2017
por: Benedict, Kaitlin, et al.
Publicado: (2020)

Direct and Indirect Costs of Infectious Conjunctivitis in a Commercially Insured Population in the United States
por: Pepose, Jay S, et al.
Publicado: (2020)

Cannabis Use and Fungal Infections in a Commercially Insured Population, United States, 2016
por: Benedict, Kaitlin, et al.
Publicado: (2020)

Health Care Costs of Anal Cancer in a Commercially Insured Population in the United States
por: Wu, Chi-Fang, et al.
Publicado: (2018)

Economic Burden of West Nile Virus in the United States
por: Barrett, Alan D. T.
Publicado: (2014)

The Economic Burden of Obesity by Glycemic Stage in the United States
por: Li, Qian, et al.
Publicado: (2015)

The potential economic burden of Zika in the continental United States
por: Lee, Bruce Y., et al.
Publicado: (2017)

Economic Burden of Legionnaires’ Disease, United States, 2014
por: Baker-Goering, Madeleine, et al.
Publicado: (2021)

Prevalence, clinical and economic burden of mucormycosis-related hospitalizations in the United States: a retrospective study
por: Kontoyiannis, Dimitrios P., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_3m1tvqam5itbntcr1j1j4bnc88